Suggestions
Tony Hickson
Chief Business Officer at Cancer Research UK (CRUK) and Cancer Research Horizons
Tony Hickson is the Chief Business Officer for Cancer Research UK (CRUK) and Cancer Research Horizons.12 He holds a BSc and MBA, and is certified as a CLP (Certified Licensing Professional) and RTTP (Registered Technology Transfer Professional).1
In his role, Hickson leads the Commercial Partnerships team of Cancer Research Horizons.1 This position involves overseeing the business aspects of cancer research and its commercial applications, likely focusing on translating scientific discoveries into practical treatments and technologies.
Hickson's professional background demonstrates a strong commitment to advancing cancer research through business strategies and partnerships. His expertise in technology transfer and licensing suggests he plays a crucial role in bridging the gap between scientific research and commercial development in the field of oncology.
On September 5, 2024, Hickson made a LinkedIn post related to pediatric cancers, indicating his ongoing involvement and interest in various aspects of cancer research and treatment.3
Additionally, in April 2022, Hickson announced that he was starting a new position as Chief Translation Advisor at Cancer Research UK, showcasing his evolving role within the organization.4
Highlights
This month is Childhood Cancer Awareness Month and today we’re officially launching C-Further, a new $36m internationally focused consortium purpose-built with LifeArc to create more targeted therapeutics for #PaediatricCancers and to address the market failure we are observing.
Children are not small adults and treating them with aggressive chemo/radiotherapy or drugs designed for adults fails to address their unique biology and can leave them with long term side effects.
C-Further has been created to bridge this crucial gap and initiate the drug discovery process towards producing more child-first targeted medicines for children and young people with cancer.
We are looking for those who share our vision and can contribute new start points for drug discovery or can help us scale the programme. Find out how you can help and partner with us: https://bit.ly/4dN6V9x
We’re at the start of an exciting journey. Please join our movement and help us spread the word. Cancer Research UK (CRUK) #OnMyHorizon #CFurther #PediatricOncology #ChildhoodCancerAwareness
Great to see that UK biotechs can do 'US style' Series A rounds too. We are very pleased to support one of the most exciting new #ADC companies on their journey to address significant unmet needs for cancer patients. Myricx Bio: https://lnkd.in/ecbrBTW3 Robin Carr Cancer Research Horizons Novo Holdings Abingworth Sofinnova Partners Jonathan Tobin Maina Bhaman Roberto Solari Ed Tate
